{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:48:37Z","timestamp":1793015317278,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Commercialization Promotion Agency for R&D Outcomes","award":["RS-2024-00486802"],"award-info":[{"award-number":["RS-2024-00486802"]}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22203MFDS539"],"award-info":[{"award-number":["22203MFDS539"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34675-z","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T21:01:42Z","timestamp":1767733302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LC2767 alleviates LPS-induced liver injury and fibrosis by regulating FXR expression, NF-\u03baB activation, and gut microbiota"],"prefix":"10.1038","volume":"16","author":[{"given":"Dong-Yun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Min","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"34675_CR1","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.33549\/physiolres.933506","volume":"65","author":"H Farghali","year":"2016","unstructured":"Farghali, H., Kgalalelo Kemelo, M., Wojnarov\u00e1, L. & Kutinov\u00e1 Canov\u00e1, N. In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs. Physiol. Res. 65, S417\u2013s425. https:\/\/doi.org\/10.33549\/physiolres.933506 (2016).","journal-title":"Physiol. Res."},{"key":"34675_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17425255.2022.2122810","volume":"18","author":"DE Di Zeo-S\u00e1nchez","year":"2022","unstructured":"Di Zeo-S\u00e1nchez, D. E. et al. Modeling drug-induced liver injury: current status and future prospects. Expert Opin. Drug Metab. Toxicol. 18, 555\u2013573. https:\/\/doi.org\/10.1080\/17425255.2022.2122810 (2022).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"34675_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","volume":"18","author":"J Maurice","year":"2018","unstructured":"Maurice, J. & Manousou, P. Non-alcoholic fatty liver disease. Clin. Med. (Lond). 18, 245\u2013250. https:\/\/doi.org\/10.7861\/clinmedicine.18-3-245 (2018).","journal-title":"Clin. Med. (Lond)"},{"key":"34675_CR4","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107, E., Mikhailidis, D. P. & Mantzoros, C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119, 154770. https:\/\/doi.org\/10.1016\/j.metabol.2021.154770 (2021).","journal-title":"Metabolism"},{"key":"34675_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224. https:\/\/doi.org\/10.1016\/s0140-6736(20)32511-3 (2021).","journal-title":"Lancet"},{"key":"34675_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","volume":"292","author":"R Paternostro","year":"2022","unstructured":"Paternostro, R. & Trauner, M. Current treatment of non-alcoholic fatty liver disease. J. Intern. Med. 292, 190\u2013204. https:\/\/doi.org\/10.1111\/joim.13531 (2022).","journal-title":"J. Intern. Med."},{"key":"34675_CR7","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","volume":"20","author":"AJ Czaja","year":"2014","unstructured":"Czaja, A. J. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J. Gastroenterol. 20, 2515\u20132532. https:\/\/doi.org\/10.3748\/wjg.v20.i10.2515 (2014).","journal-title":"World J. Gastroenterol."},{"key":"34675_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An, L. et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J. Gastrointest. Surg. 26, 671\u2013683. https:\/\/doi.org\/10.1007\/s11605-021-05188-7 (2022).","journal-title":"J. Gastrointest. Surg."},{"key":"34675_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nutres.2019.03.008","volume":"67","author":"I Kim","year":"2019","unstructured":"Kim, I. Lactobacillus plantarum LC27 and bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice. Nutr. Res. 67, 78\u201389. https:\/\/doi.org\/10.1016\/j.nutres.2019.03.008 (2019).","journal-title":"Nutr. Res."},{"key":"34675_CR10","doi-asserted-by":"publisher","first-page":"e47713","DOI":"10.1371\/journal.pone.0047713","volume":"7","author":"KA Kim","year":"2012","unstructured":"Kim, K. A., Gu, W., Lee, I. A., Joh, E. H. & Kim, D. H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 7, e47713. https:\/\/doi.org\/10.1371\/journal.pone.0047713 (2012).","journal-title":"PLoS One"},{"key":"34675_CR11","doi-asserted-by":"publisher","first-page":"13897","DOI":"10.1038\/s41598-018-31764-0","volume":"8","author":"HM Jang","year":"2018","unstructured":"Jang, H. M., Lee, K. E., Lee, H. J. & Kim, D. H. Immobilization stress-induced Escherichia coli causes anxiety by inducing NF-\u03baB activation through gut microbiota disturbance. Sci. Rep. 8, 13897. https:\/\/doi.org\/10.1038\/s41598-018-31764-0 (2018).","journal-title":"Sci. Rep."},{"key":"34675_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/mi.2017.49","volume":"11","author":"SE Jang","year":"2018","unstructured":"Jang, S. E. et al. Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice. Mucosal Immunol. 11, 369\u2013379. https:\/\/doi.org\/10.1038\/mi.2017.49 (2018).","journal-title":"Mucosal Immunol."},{"key":"34675_CR13","doi-asserted-by":"publisher","first-page":"770986","DOI":"10.3389\/fendo.2021.770986","volume":"12","author":"T Kessoku","year":"2021","unstructured":"Kessoku, T. et al. Endotoxins and non-alcoholic fatty liver disease. Front. Endocrinol. (Lausanne). 12, 770986. https:\/\/doi.org\/10.3389\/fendo.2021.770986 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"34675_CR14","doi-asserted-by":"publisher","unstructured":"Liu, L. et al. Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer. Gastroenterol. Res. Pract. 2021 (6645970). https:\/\/doi.org\/10.1155\/2021\/6645970 (2021).","DOI":"10.1155\/2021\/6645970"},{"key":"34675_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","volume":"101","author":"C Staley","year":"2017","unstructured":"Staley, C., Weingarden, A. R., Khoruts, A. & Sadowsky, M. J. Interaction of gut microbiota with bile acid metabolism and its influence on disease States. Appl. Microbiol. Biotechnol. 101, 47\u201364. https:\/\/doi.org\/10.1007\/s00253-016-8006-6 (2017).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"34675_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.intimp.2012.10.026","volume":"15","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int. Immunopharmacol. 15, 30\u201337. https:\/\/doi.org\/10.1016\/j.intimp.2012.10.026 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"34675_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00394-015-0904-3","volume":"55","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. Eur. J. Nutr. 55, 821\u2013831. https:\/\/doi.org\/10.1007\/s00394-015-0904-3 (2016).","journal-title":"Eur. J. Nutr."},{"key":"34675_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/hep.21750","volume":"46","author":"J Ewaschuk","year":"2007","unstructured":"Ewaschuk, J. et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46, 841\u2013850. https:\/\/doi.org\/10.1002\/hep.21750 (2007).","journal-title":"Hepatology"},{"key":"34675_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fmicb.2019.00477","volume":"10","author":"J Gao","year":"2019","unstructured":"Gao, J. et al. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Front. Microbiol. 10, 477. https:\/\/doi.org\/10.3389\/fmicb.2019.00477 (2019).","journal-title":"Front. Microbiol."},{"key":"34675_CR20","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1038\/s41598-018-25775-0","volume":"8","author":"SE Jang","year":"2018","unstructured":"Jang, S. E., Jeong, J. J., Kim, J. K., Han, M. J. & Kim, D. H. Simultaneous amelioratation of colitis and liver injury in mice by bifidobacterium longum LC67 and Lactobacillus plantarum LC27. Sci. Rep. 8, 7500. https:\/\/doi.org\/10.1038\/s41598-018-25775-0 (2018).","journal-title":"Sci. Rep."},{"key":"34675_CR21","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1039\/c8fo00252e","volume":"9","author":"WG Kim","year":"2018","unstructured":"Kim, W. G., Kim, H. I., Kwon, E. K., Han, M. J. & Kim, D. H. Lactobacillus plantarum LC27 and bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-\u03baB activation through restoration of the disturbed gut microbiota. Food Funct. 9, 4255\u20134265. https:\/\/doi.org\/10.1039\/c8fo00252e (2018).","journal-title":"Food Funct."},{"key":"34675_CR22","doi-asserted-by":"publisher","unstructured":"Milosevic, I. et al. Gut-Liver Axis, gut Microbiota, and its modulation in the management of liver diseases: A review of the literature. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20020395 (2019).","DOI":"10.3390\/ijms20020395"},{"key":"34675_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1301\/nr.2007.dec.s170-s172","volume":"65","author":"B Bistrian","year":"2007","unstructured":"Bistrian, B. Systemic response to inflammation. Nutr. Rev. 65, 170\u2013172. https:\/\/doi.org\/10.1301\/nr.2007.dec.s170-s172 (2007).","journal-title":"Nutr. Rev."},{"key":"34675_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jceh.2013.03.225","volume":"3","author":"M Bawa","year":"2013","unstructured":"Bawa, M. & Saraswat, V. A. Gut-liver axis: role of inflammasomes. J. Clin. Exp. Hepatol. 3, 141\u2013149. https:\/\/doi.org\/10.1016\/j.jceh.2013.03.225 (2013).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"34675_CR25","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.ajpath.2017.08.005","volume":"187","author":"M Nighot","year":"2017","unstructured":"Nighot, M. et al. Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by toll-like receptor 4\/Myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression. Am. J. Pathol. 187, 2698\u20132710. https:\/\/doi.org\/10.1016\/j.ajpath.2017.08.005 (2017).","journal-title":"Am. J. Pathol."},{"key":"34675_CR26","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1038\/s41598-022-13629-9","volume":"12","author":"HM Jang","year":"2022","unstructured":"Jang, H. M. et al. Enterococcus faecium and pediococcus acidilactici deteriorate Enterobacteriaceae-induced depression and colitis in mice. Sci. Rep. 12, 9389. https:\/\/doi.org\/10.1038\/s41598-022-13629-9 (2022).","journal-title":"Sci. Rep."},{"key":"34675_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","volume":"182","author":"S Guo","year":"2013","unstructured":"Guo, S., Al-Sadi, R., Said, H. M. & Ma, T. Y. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182, 375\u2013387. https:\/\/doi.org\/10.1016\/j.ajpath.2012.10.014 (2013).","journal-title":"Am. J. Pathol."},{"key":"34675_CR28","doi-asserted-by":"publisher","first-page":"104093","DOI":"10.1016\/j.etap.2023.104093","volume":"99","author":"D Ezhilarasan","year":"2023","unstructured":"Ezhilarasan, D. Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models. Environ. Toxicol. Pharmacol. 99, 104093. https:\/\/doi.org\/10.1016\/j.etap.2023.104093 (2023).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"34675_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jff.2017.09.036","volume":"38","author":"EK Kwon","year":"2017","unstructured":"Kwon, E. K., Kang, G. D., Kim, W. K., Han, M. J. & Kim, D. H. Lactobacillus plantarum LC27 and bifidobacterium longum LC67 simultaneously alleviate ethanol-induced gastritis and hepatic injury in mice. J. Funct. Foods. 38, 389\u2013398. https:\/\/doi.org\/10.1016\/j.jff.2017.09.036 (2017).","journal-title":"J. Funct. Foods."},{"key":"34675_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625\u2013637. https:\/\/doi.org\/10.1038\/s41575-022-00631-9 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"34675_CR31","doi-asserted-by":"publisher","first-page":"110855","DOI":"10.1016\/j.foodres.2021.110855","volume":"151","author":"C Yin","year":"2022","unstructured":"Yin, C. et al. Differences of gut microbiota composition in mice supplied with polysaccharides from \u03b3-irradiated and non-irradiated schizophyllum commune. Food Res. Int. 151, 110855. https:\/\/doi.org\/10.1016\/j.foodres.2021.110855 (2022).","journal-title":"Food Res. Int."},{"key":"34675_CR32","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41598-017-00671-1","volume":"7","author":"ND Thiele","year":"2017","unstructured":"Thiele, N. D. et al. TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice. Sci. Rep. 7, 714. https:\/\/doi.org\/10.1038\/s41598-017-00671-1 (2017).","journal-title":"Sci. Rep."},{"key":"34675_CR33","doi-asserted-by":"publisher","first-page":"116116","DOI":"10.1016\/j.biopha.2023.116116","volume":"171","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms. Biomed. Pharmacother. 171, 116116. https:\/\/doi.org\/10.1016\/j.biopha.2023.116116 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"34675_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/hep.510260620","volume":"26","author":"T Takahara","year":"1997","unstructured":"Takahara, T. et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology 26, 1521\u20131529. https:\/\/doi.org\/10.1002\/hep.510260620 (1997).","journal-title":"Hepatology"},{"key":"34675_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1478-3231.2004.0946.x","volume":"24","author":"X Zhou","year":"2004","unstructured":"Zhou, X. et al. Expression of matrix metalloproteinase-2 and \u2013\u200914 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int. 24, 492\u2013501. https:\/\/doi.org\/10.1111\/j.1478-3231.2004.0946.x (2004).","journal-title":"Liver Int."},{"key":"34675_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","volume":"44\u201346","author":"S Duarte","year":"2015","unstructured":"Duarte, S., Baber, J., Fujii, T. & Coito, A. J. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 44\u201346, 147\u2013156. https:\/\/doi.org\/10.1016\/j.matbio.2015.01.004 (2015).","journal-title":"Matrix Biol."},{"key":"34675_CR37","doi-asserted-by":"publisher","first-page":"115740","DOI":"10.1016\/j.bcp.2023.115740","volume":"215","author":"T Luangmonkong","year":"2023","unstructured":"Luangmonkong, T., Parichatikanond, W. & Olinga, P. Targeting collagen homeostasis for the treatment of liver fibrosis: opportunities and challenges. Biochem. Pharmacol. 215, 115740. https:\/\/doi.org\/10.1016\/j.bcp.2023.115740 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"34675_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/bj2440075","volume":"244","author":"L Ala-Kokko","year":"1987","unstructured":"Ala-Kokko, L., Pihlajaniemi, T., Myers, J. C., Kivirikko, K. I. & Savolainen, E. R. Gene expression of type I, III and IV collagens in hepatic fibrosis induced by Dimethylnitrosamine in the rat. Biochem. J. 244, 75\u201379. https:\/\/doi.org\/10.1042\/bj2440075 (1987).","journal-title":"Biochem. J."},{"key":"34675_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68\u201369","author":"E Roeb","year":"2018","unstructured":"Roeb, E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 68\u201369, 463\u2013473. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.012 (2018).","journal-title":"Matrix Biol."},{"key":"34675_CR40","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1111\/liv.12337","volume":"34","author":"O Garcia-Irigoyen","year":"2014","unstructured":"Garcia-Irigoyen, O. et al. Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair. Liver Int. 34, e257\u2013270. https:\/\/doi.org\/10.1111\/liv.12337 (2014).","journal-title":"Liver Int."},{"key":"34675_CR41","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1124\/jpet.105.084905","volume":"314","author":"S Fiorucci","year":"2005","unstructured":"Fiorucci, S. et al. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J. Pharmacol. Exp. Ther. 314, 584\u2013595. https:\/\/doi.org\/10.1124\/jpet.105.084905 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"34675_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1124\/mol.110.068247","volume":"80","author":"J Li","year":"2011","unstructured":"Li, J. et al. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol. Pharmacol. 80, 191\u2013200. https:\/\/doi.org\/10.1124\/mol.110.068247 (2011).","journal-title":"Mol. Pharmacol."},{"key":"34675_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"JYL Chiang","year":"2020","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 4, 47\u201363. https:\/\/doi.org\/10.1016\/j.livres.2020.05.001 (2020).","journal-title":"Liver Res."},{"key":"34675_CR44","doi-asserted-by":"publisher","first-page":"101641","DOI":"10.1016\/j.clinre.2021.101641","volume":"45","author":"T Ren","year":"2021","unstructured":"Ren, T., Pang, L., Dai, W., Wu, S. & Kong, J. Regulatory mechanisms of the bile salt export pump (BSEP\/ABCB11) and its role in related diseases. Clin. Res. Hepatol. Gastroenterol. 45, 101641. https:\/\/doi.org\/10.1016\/j.clinre.2021.101641 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"34675_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/164_2019_228","volume":"256","author":"JD Schumacher","year":"2019","unstructured":"Schumacher, J. D. & Guo, G. L. Pharmacologic modulation of bile Acid-FXR-FGF15\/FGF19 pathway for the treatment of nonalcoholic steatohepatitis. Handb. Exp. Pharmacol. 256, 325\u2013357. https:\/\/doi.org\/10.1007\/164_2019_228 (2019).","journal-title":"Handb. Exp. Pharmacol."},{"key":"34675_CR46","doi-asserted-by":"publisher","first-page":"62780","DOI":"10.18632\/oncotarget.19376","volume":"8","author":"Z Liang","year":"2017","unstructured":"Liang, Z. et al. AMPK: a novel target for treating hepatic fibrosis. Oncotarget 8, 62780\u201362792. https:\/\/doi.org\/10.18632\/oncotarget.19376 (2017).","journal-title":"Oncotarget"},{"key":"34675_CR47","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLoS Biol."},{"key":"34675_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40168-020-00881-2","volume":"8","author":"KE Lee","year":"2020","unstructured":"Lee, K. E. et al. The extracellular vesicle of gut microbial paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment. Microbiome 8, 107. https:\/\/doi.org\/10.1186\/s40168-020-00881-2 (2020).","journal-title":"Microbiome"},{"key":"34675_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2020.00273","volume":"11","author":"JK Kim","year":"2020","unstructured":"Kim, J. K., Lee, K. E., Lee, S. A., Jang, H. M. & Kim, D. H. Interplay between human gut bacteria Escherichia coli and Lactobacillus mucosae in the occurrence of neuropsychiatric disorders in mice. Front. Immunol. 11, 273. https:\/\/doi.org\/10.3389\/fimmu.2020.00273 (2020).","journal-title":"Front. Immunol."},{"key":"34675_CR50","doi-asserted-by":"publisher","unstructured":"Kroh, A. et al. Mouse models of nonalcoholic steatohepatitis: Head-to-Head comparison of dietary models and impact on inflammation and animal welfare. Gastroenterol. Res. Pract. 2020, 7347068. https:\/\/doi.org\/10.1155\/2020\/7347068 (2020).","DOI":"10.1155\/2020\/7347068"},{"key":"34675_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2024.02.031","volume":"118","author":"X Ma","year":"2024","unstructured":"Ma, X. et al. Lipopolysaccharide-producing Veillonella infantium and Escherichia fergusonii cause vagus nerve-mediated cognitive impairment in mice. Brain Behav. Immun. 118, 136\u2013148. https:\/\/doi.org\/10.1016\/j.bbi.2024.02.031 (2024).","journal-title":"Brain Behav. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34675-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:06:21Z","timestamp":1770026781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34675-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34675"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34675-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Committee for the Care and Use of Laboratory Animals in the Kyung Hee University (IACUC No.: KHUASP(SE)-23087, KHUASP(SE)-23390) and conducted in accordance with the university\u2019s guidelines for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"4466"}}